tm logo
EGALITY SCIENCES
Live/Registered
REGISTERED

on 23 Jan 2024

Last Applicant/ Owned by

1300 MCGOWEN ST STE 80

Houston

TX

770041141

Serial Number

97671280 filed on 10th Nov 2022

Registration Number

7284161 registered on 23rd Jan 2024

in the Principal Register

Correspondent Address

Rafael E. Saavedra Morell

Rafael E. Saavedra Morell

COND. VALLES DE TORRIMAR APT. H 302

GUAYNABO,PR 00966

Filing Basis

1. filed as use application

2. use application currently

Disclaimer

NO DATA

EGALITY SCIENCES

Medical and scientific research, namely, conducting clinical trials and decentralized clinical trials for others; Providing medical and scientific research information in the field of clinical trials and decentralized clinical trials; Research and development in the field of protocol development for clinical research studies and decentralized clinical trials; Consulting services for others in the Read More

Classification Information


Class [042]
Computer & Software Services & Scientific Services


Medical and scientific research, namely, conducting clinical trials and decentralized clinical trials for others; Providing medical and scientific research information in the field of clinical trials and decentralized clinical trials; Research and development in the field of protocol development for clinical research studies and decentralized clinical trials; Consulting services for others in the field of design, planning, and implementation project management of scientific research, clinical trials and decentralized clinical trials; Quality management services, namely, performing corrective and preventive actions (CAPA) in the field of clinical trials and decentralized clinical trials; Clinical research organization (CRO) services, namely, conducting clinical trials, and decentralized clinical trials for others


First Use Date in General

26th Mar 2022

First Use Date in Commerce

26th Mar 2022

Class [035]
Advertising, Business & Retail Services


Regulatory submission management, namely, assisting others in preparing and filing applications for new drugs with governmental regulatory bodies; Business consulting and management in the field of clinical trials and decentralized clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical, and biotechnology companies to assist them with clinical research, market aligned planning, clinical trials, decentralized clinical trials, and applications for drug approval; Business management consulting services in the fields of team building, human capital investment, workplace culture, workforce assessment, business efficiency, employee wellness, leadership development, personnel management, leadership, professional development and creativity


First Use Date in General

26th Mar 2022

First Use Date in Commerce

26th Mar 2022

Specimens


EGALITY SCIENCES specimenEGALITY SCIENCES specimenEGALITY SCIENCES specimenEGALITY SCIENCES specimenEGALITY SCIENCES specimenEGALITY SCIENCES specimenEGALITY SCIENCES specimenEGALITY SCIENCES specimenEGALITY SCIENCES specimenEGALITY SCIENCES specimenEGALITY SCIENCES specimenEGALITY SCIENCES specimen

Mark Details


Serial Number

No 97671280

Mark Type

No Service Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Design Code(s)

05.01.02 -

Trees or bushes with a generally rounded shape, including deciduous trees

05.13.01 -

Roots, including ginger and ginseng

26.01.29 -

Helixes

26.17.01 -

Straight line(s), band(s) or bar(s)

26.17.05 -

Horizontal line(s), band(s) or bar(s)

Legal History


Show more

Status DateAction Taken
23rd Jan 2024REGISTERED-PRINCIPAL REGISTER
23rd Jan 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
07th Nov 2023PUBLISHED FOR OPPOSITION
07th Nov 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
18th Oct 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04th Oct 2023APPROVED FOR PUB - PRINCIPAL REGISTER
01st Sep 2023TEAS/EMAIL CORRESPONDENCE ENTERED
31st Aug 2023NON-FINAL ACTION WRITTEN
31st Aug 2023NON-FINAL ACTION E-MAILED
31st Aug 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED